evomed at ESTRO 2026: Shaping the Future of Radiation Oncology

The team of evomed proudly participated in ESTRO 2026, held this year in Stockholm — one of the most important international congresses dedicated to radiation oncology and cancer care innovation.

ESTRO 2026 brought together leading clinicians, medical physicists, radiation therapists, researchers, and technology companies from across the globe, creating a unique environment for scientific exchange and collaboration around the future of radiotherapy.

During the congress, the evomed team had the opportunity to meet with key industry leaders and strategic partners who are actively shaping the next generation of radiation oncology technologies. Discussions focused on the rapid evolution of precision radiotherapy, Surface Guided Radiation Therapy (SGRT), adaptive workflows, patient safety, automation, and the integration of advanced technologies into modern cancer treatment.

Beyond the technological advancements presented during the congress, ESTRO 2026 was also an important opportunity to strengthen existing collaborations and establish new strategic partnerships that will contribute to the further development of radiation oncology in Greece.

At evomed, our mission remains clear:to continuously bring innovative and clinically valuable technologies to healthcare professionals and cancer centers across Greece and Cyprus, supporting safer, more accurate, and more patient-centered treatments.

Participation in international scientific congresses such as ESTRO is an essential part of our commitment to staying at the forefront of medical technology and ensuring that the local oncology community remains connected with the latest global developments.

We would like to thank all our partners, collaborators, and healthcare professionals we met during ESTRO 2026 and look forward to transforming these discussions into meaningful clinical progress for the future of radiation oncology.

Looking Ahead

The future of radiotherapy is being shaped through collaboration, innovation, and clinical excellence — and evomed remains committed to actively contributing to this journey.

#ESTRO2026 #Radiotherapy #RadiationOncology #CancerCare #SGRT #Innovation #VisionRT #HealthcareInnovation #MedicalTechnology #evomed